Last reviewed · How we verify
NCT06709508
Retrospective Evaluation of Prosthetic Complications and Peri-implant Bone Resorption in Implant-supported Single Unit Fixed Restorations
trial testing Examination group in Implant Clinical Survival in 100 participants. Completed in 8 April 2024.
8 April 2024
Quick facts
| Lead sponsor | Özer İşisağ |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 8 April 2023 |
| Primary completion | 8 April 2024 |
| Estimated completion | 8 April 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Examination group
Conditions studied
- Implant Clinical Survival — all drugs for Implant Clinical Survival →
- Restoration Survival — all drugs for Restoration Survival →
Sponsor
Özer İşisağ
Who can join
18 and older, any sex, with Implant Clinical Survival or Restoration Survival. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluated the one-year outcomes of implant-supported single-tooth fixed restorations used to replace missing teeth. The aim was to assess the success rates of dental implants and identify potential complications during treatment. A total of 100 individuals aged between 20 and 64 participated in the study. Patients were evaluated one year after their implant treatments through clinical examinations and radiographic imaging.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06709508
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06709508 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Özer İşisağ
- Last refreshed: 29 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06709508.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing